New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation

<div class="page" title="Page 4"><div class="section"><div class="layoutArea"><div class="column"><p><span>New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in p...

Full description

Bibliographic Details
Main Author: article Editorial
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-11-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Online Access:http://www.rpcardio.ru/jour/article/view/332
Description
Summary:<div class="page" title="Page 4"><div class="section"><div class="layoutArea"><div class="column"><p><span>New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation </span></p></div></div></div></div>
ISSN:1819-6446
2225-3653